Bone Biologics OverviewBone Biologics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BBLG.
Quarterly EBIT
-$805.05K
↑ 22.48% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$2.90M
↑ 33.47% YoY
Trailing 12 months ending Mar 31, 2026
Bone Biologics OverviewEBIT (Earnings Before Interest and Taxes) analysis for BBLG.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026